Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
372.00
0.00 (0.00%)
At close: Nov 14, 2025
SHA:688506 Revenue
Sichuan Biokin Pharmaceutical had revenue of 1.89B CNY in the quarter ending September 30, 2025, with 1,625.08% growth. This brings the company's revenue in the last twelve months to 2.23B, down -61.93% year-over-year. In the year 2024, Sichuan Biokin Pharmaceutical had annual revenue of 5.82B with 936.31% growth.
Revenue (ttm)
2.23B
Revenue Growth
-61.93%
P/S Ratio
68.93
Revenue / Employee
883.00K
Employees
2,521
Market Cap
153.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.82B | 5.26B | 936.31% |
| Dec 31, 2023 | 561.87M | -141.41M | -20.11% |
| Dec 31, 2022 | 703.28M | -93.45M | -11.73% |
| Dec 31, 2021 | 796.73M | -215.98M | -21.33% |
| Dec 31, 2020 | 1.01B | -193.91M | -16.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 43.88B |
| Huadong Medicine | 43.09B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Medicine | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |